Wilson Francis P FP

Show results for

Unknown (36)
Metabolomics (2)
Transcriptomics (1)

Organisms

Homo sapiens (1)

Repository

MetaboLights (2)
biostudies-arrayexpress (1)

Technology Type

Mass spectrometry (2)

Instrument Platform

Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2012 (1)
2024 (1)
2023 (1)

CHEBI ID

CHEBI:10029 (2)
CHEBI:10037 (2)
CHEBI:10117 (2)
CHEBI:10121 (2)
CHEBI:10135 (2)
CHEBI:10137 (2)
CHEBI:1014 (2)
CHEBI:102216 (2)
CHEBI:102484 (2)
CHEBI:102524 (2)
CHEBI:111173 (2)
CHEBI:113 (2)
CHEBI:125201 (2)
CHEBI:125472 (2)
CHEBI:132244 (2)
CHEBI:132448 (2)
CHEBI:132612 (2)
CHEBI:132837 (2)
CHEBI:132983 (2)
CHEBI:133013 (2)
CHEBI:133094 (2)
CHEBI:133460 (2)
CHEBI:133530 (2)
CHEBI:133544 (2)
CHEBI:133570 (2)
CHEBI:133914 (2)
CHEBI:133919 (2)
CHEBI:134682 (2)
CHEBI:134745 (2)
CHEBI:134750 (2)

Metabolite Name

(+)-10-deoxymethynolide (2)
(+)-castanospermine (2)
(+/-)-camphoric acid (2)
(+/-)12(13)-dihome (2)
(2r)-3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(octanoyloxy)propyl octanoate (2)
(3a,5b,7a,12a)-24-[(carboxymethyl)amino]-1,12-dihydroxy-24-oxocholan-3-yl-b-d-glucopyranosiduronic acid (2)
(5z,13e,15r)-15-hydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid (2)
(e)-4-methoxycinnamic acid (2)
(e)-parinaric acid (2)
(r)-paliperidone palmitate (2)
1,3,7-trimethyluric acid (2)
1-naphthylacetylspermine (2)
1-oleoyl-rac-glycerol (2)
10-gingerol (2)
11-deoxocucurbitacin i (2)
11-deoxy-pge1 (2)
13(s)-hotre (2)
13(s)-hpotre (2)
16-feruloyloxypalmitic acid (2)
1alpha,25-dihydroxy-2beta-(4-hydroxybutoxy)vitamin d3 (2)
2,5-dimethyl-4-ethoxy-3(2h)-furanone (2)
2,6-di-tert-butylhydroquinone (2)
2-(diethoxymethyl)furan (2)
2-aminoadenosine (2)
2-hydroxy-5-vinylphenyl hydrogen sulfate (2)
2-hydroxyhippuric acid (2)
2-methylcitric acid (2)
2ee5599gqs (2)
3,4,5-trimethoxyhydrocinnamic acid (2)
3,4-dimethoxyphenethylamine (2)

Study type

Methylation profiling by array (1)

Release Date

2021 (6)
2024 (5)
2025 (4)
2022 (4)
2020 (4)
2010 (4)
2018 (3)
2012 (2)
2016 (2)
2023 (1)
2013 (1)
2011 (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

450k Analysis of 3 FF HPV+ and 3 FF HPV- HNSCC samples

The methylation analysis of 3 FF HPV+ HNSCC samples and 21 FP HPV- HNSCC samples by Infinium HumanMethylation450 BeadChip Analysis of 6 450k methylation profiles, comprising 3 HPV+ HNSCC samples and 3 HPV- HNSCC samples

ORGANISM(S): Homo sapiens

2012-11-30 | E-GEOD-38268 | biostudies-arrayexpress

Transcriptomic and metabolomic analysis of liver cirrhosis

Liver cirrhosis is one of the leading causes of decreased life expectancy worldwide. However, the molecular mechanisms underlying the development of liver cirrhosis remain unclear. In this study, we performed a comprehensive analysis using transcriptome and metabolome sequencing to explore the genes...

2024-08-07 | MTBLS5665 | MetaboLights

Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy

OBJECTIVE: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare acquired immune-mediated neuropathy. Although microbial infection is potentially a contributing factor, a causative link between CIDP and microbial infection remains unclear. There is also no de...

2023-01-16 | MTBLS5828 | MetaboLights

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.

Not available

S-EPMC4998967 | biostudies-literature

Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.

Not available

S-EPMC3737287 | biostudies-literature

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.

Not available

S-EPMC8927425 | biostudies-literature

Effects of combination lipid therapy in type 2 diabetes mellitus.

Not available